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Purpose: Local compression has been advocated for the treatment of femoral artery 
pseudoaneurysms. Although it is effective and has a high success rate, this method bears 
some limitations; among them are prolonged procedure time, discomfort for patients, 
and recurrence. As a potent thrombosis-inducing a ent, thrombin has been used topi- 
caUy, and occasionally intravascularly, for hemostasis. Pseudoaneurysms with a narrow 
connecting tract to the native artery may be suitable for treatment with thrombin 
injection to induce intracavitary coagulation. 
Methods: Patients with pseudoaneurysms of the femoral artery were evaluated by ultra- 
sonography. Under ultrasound guidance, an intravenous catheter was introduced percu- 
taneously into the pseudoaneurysm, with the catheter position confirmed by contrast 
ultrasonography. One thousand units of thrombin dissolved in normal saline solution 
was then injected slowly into the pseudoaneurysm through the catheter to induce 
thrombosis. The patients were monitored closely for any adverse ffects after thrombin 
injection. 
Results: A total of five patients with femoral artery pseudoaneurysms were treated with 
direct percutaneous thrombin injection under ultrasound guidance. Within seconds of 
thrombin injection thrombus formation was evident, and blood flow in the pseudoaneu- 
rysm soon ceased when the thrombosis extended to the connecting tract. All procedures 
were uneventful and successful. No recurrence was noted during follow-up periods of 1 
to 28 months. 
Conclusion: Our initial experience with the small number of patients demonstrates the 
simplicity, lack of morbidity, and high success rate for ultrasotmd-guided percutaneous 
thrombin injection for the treatment of femoral artery pseudoaneurysms. (J Vase Surg 
1997;26:18-23.) 
Pseudoaneurysm of the peripheral arteries was 
previously regarded as an infrequent complication of 
cardiac catheterization. ~ 7 Yet as a result of  wide 
application of the catheterization technique for en- 
doluminal therapy in recent years, the incidence of 
this complication has markedly increased, s-n In the 
cardiovascular interventions, larger vascular sheaths 
are frequently applied and anticoagulants or throm- 
bolytic agents are commonly used, which may be 
responsible for this increase.~la2 
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Although surgical repair was the standard method 
of management for pseudoaneurysms of the peripheral 
m'teries, 13,14 nonsurgical methods of treatment have 
been developed in recent  years. 15-22 Walker et al. 23 first 
used thrombin to treat pseudoaneurysms translumi- 
nally through a catheter. Cope and Zeit 2° reported the 
percutaneous method of using thrombin to treat 
pseudoanettrysms of the peripheral arteries. Yet the 
method of inducing thrombosis with intravascular in- 
jection of thrombin seems not to be gaining wide ac- 
ceptance, possibly as a result of the lack of safety assur- 
ance for intravascular use ofthrombin. The purpose of 
this small study was to determine whether percutane- 
ous thrombin injection could effectively treat pseudo- 
aneurysms without any serious complications. 
PATIENTS AND METHODS 
From February 1994 to July 1996, 10 patients 
with pseudoaneurysms of the femoral artery as a 
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Fig. 1. Left iliac artery angiogram of a 38-year-old male patient (patient 5, Table I) with 
coronary artery disease. This patient underwent one cardiac catheterization 35 days before. 
Pseudoaneurysm was detected several days after that procedure but was not treated. In this 
catheterization, percutaneous transluminal coronary angioplasty was performed. The pseudo- 
aneurysm was studied with angiography. It was found that this pseudoaneurysm arose from left 
external femoral artery. It consists of two chambers connected by a narrow neck (arrowhead). 
Table I. Basic information of patients 
Patient Age~sex Underlying condition Catheterizaiton procedure 
59/F Rheumatic mitral stenosis, mild mitral insufficiency PTMC 
80/F Aortic steno-insufficiency Routine cardiac catheterization 
72/F Coronary heart disease PTCA 
68/M Severe chest pain, normal coronary angiography Routine cardiac catheterization 
38/M Coronary heart disease PTCA 
PTCA, Percutaneous transluminal coronary angioplasty; PTMC, percutaneous transvenous mitral commisurotomy. 
complication of cardiac atheterization was treated in 
our Institute. Among them, five patients did not 
agree to accept hrombin injection and were treated 
with external compression, which resulted in success- 
fill occlusion of the pseudoaneurysm in three pa- 
tients. The two patients in whom external compres- 
sion failed underwent surgical repair. The remaining 
five patients were u'eated with direct thrombin injec- 
tion without external compression and comprise the 
study group of this report. 
The ages of the five stud); subjects ranged from 
38 to 80 years (mean, 63 -+ 16 years, Table I). In all 
patients pseudoaneurysm was suspected because of 
the presence of a painful pulsating mass and vascular 
bruit at puncture sites. The diagnosis was then con- 
firmed by ultrasound examination i all patients and 
by angiogram in one patient (patient 5; Table I and 
Fig. 1). 
Underlying heart conditions included coronary 
artery disease in two patients, valvular heart disease in 
two patients, and severe resting chest pain in the 
remaining patient (Table I). Percutaneous trans- 
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venous mitral commissurotomy was performed on 
the patient who had rheumatic heart disease. Two 
patients with coronary artery disease were treated 
with percutaneous transluminal coronary angio- 
plasty. The remaining two patients underwent simple 
cardiac catheterization. The intervals from the pa- 
tient undergoing catheterization to the treatment of 
the pseudoaneurysm were 2 days in one patient, 3 
days in three patients, and 40 days in one patient. All 
patients received intravenous hepaa'in during cardiac 
catheterization. The patient who had rheumatic 
heart disease (patient 1, Table I) was on long-term 
warfarin medication, which was continued after per- 
cutaneous transvenous mitral commissurotomy. The 
patient with chest pain and normal coronary angio- 
grams was initially diagnosed as having unstable an- 
gina and was treated with continuous heparin infu- 
sion until the conclusion of coronary angiography. 
Two patients with coronary artery disease who un- 
derwent percutaneous transluminal coronary angio- 
plasty were treated with heparin infusion after the 
procedure for 24 hours. The remaining patient (pa- 
tient 2, Table I) was not treated with anticoagulant 
except during cardiac atheterization. 
Ultrasonographic studies, including two-dimen- 
sional and color Doppler flow mapping, were per- 
formed in all patients. The size of the pseudoaneu- 
rysm was measured, and the connecting tract 
between the femoral artery and the pseudoaneurysm 
were identified. We then explained the potential risks 
of peripheral vascular occlusion mad allergic reaction 
to bovine protein to the patients. The procedure of 
direct thrombin injection was performed only after 
informed consent was obtained. The protocol was 
approved by the institutional review board of the 
National Taiwan University Medical College. 
In performing thrombin injection for treating 
femoral artery pseudoaneurysms, local anesthesia 
with 1% lidocaine was first applied. Under ultrasound 
monitoring, a #19 intravenous catheter was intro- 
dueed into the lumen of the pseudoaneurysm. The 
position of the catheter tip could be identified by 
injecting 1to 2 ml of normal saline solution contain- 
ing micro-air bubbles. To avoid adverse regurgita- 
tion of injected thrombin into the femoral artery, the 
catheter tip was adjusted to point away from the 
connecting tract. Through the catheter 1000 units of 
thrombin (Mochida, Tol~¢o) dissolved in normal sa- 
line solution was slowly injected into the pseudoan- 
eurysm under continuous ultrasound monitoring. 
Thrombosis was evident within seconds after starting 
thrombin injection and blocked blood flow from 
femoral artery to the pseudoaneurysm. The catheter 
was then removed, and the puncture site was manu- 
ally compressed for hemostasis. The patients were 
observed for the presence of any adverse ffects and 
the intactness of the distal pulsation after the proce- 
dure. Follow-up ultrasound studies were performed 
at the conclusion of the procedure, the day after the 
procedure, and later at clinical follow-up. 
RESULTS 
The sizes of the pseudoaneurysms ranged from 
3.5 x 3.0 cm to 6.5 x 3.5 cm (longitudinal x
transverse dimensions). In four patients the pseudo- 
aneurysms were found 1 to 2 days after cardiac ath- 
eterization The remaining patient (patient 5, Table 
I) was catheterized 35days before he was referred to 
us. His pseudoaneurysm was found several days after 
the first catheterization but was not treated. The 
pseudoaneurysm was large (6.5 cm in length, 3.5 cm 
in width, and 4 cm in depth) and was composed of 
two chambers (Fig. 1). Except for the first patient, in 
whom 1000 units ofthrombin was dissolved in 10 ml 
normal saline solution, the subsequent patients were 
treated with the same dose of thrombin dissolved in 
4 ml normal saline solution. Immediately after injec- 
tion of the thrombin, thrombus formation was evi- 
dent under ultrasound visualization, which was fol- 
lowed by the termination of blood flow in the 
pseudoaneurysm (Fig. 2). 
Through careful monitoring with ultrasonogra- 
phy, the procedure was successful in all five patients, 
and no adverse reaction was detected. The distal 
pulsation was intact in all patients. The patients expe- 
rienced no fever, allerg% or local reaction. Follow-up 
ultrasound studies 1 to 28 months (mean, 11.6 
months) after treatment revealed no recurrence of 
the pseudoaneurysm in any patient. 
DISCUSSION 
After its introduction by Fellmeth et al., ~5 the 
technique of ultrasound-gnided xternal compres- 
sion has been widely applied in the treatment of 
femoral artery pseudoaneurysms) ~,~2,16,24-3° Al- 
though it has a high success rate, the method of local 
compression bears some limitations. The compres- 
sion time is relatively long) za~,zs-z7 Among 126 
treated patients, Coley et al32 found that the mean 
compression time was 42.6 + 33.9 minutes (range, 
10 to 180 minutes) for uniloculated pseudoaneu- 
rysms and 69.3 + 53.6 minutes (range, 30 to 300 
minutes) for multiloculated pseudoaneurysms. Agar- 
wal et al.26 reported a mean compression time of 
104.1 + 63.0 minutes to result in a 100% success rate 
for their patients. 
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Fig. 2. Serial ultrasonograms during percutaneous thrombin treatment of a pseudoaneurysm. 
Patient is same as in Fig. 1. A, Pseudoaneurysm consisted of two chambers (arrowheads) and 
was adjacent and superficial to the femoral arteries (arrows). B, After injection of saline solution 
with microbubbles through the catheter, appearance of contrast echoes in the chamber of 
pseudoaneurysm confirmed the position of the catheter. C, Seconds after thrombin injection, 
thrombus formation started (arrow beads). D, Thrombus extended to occupy most portions of 
the cavity of pseudoaneurysm, and blood flow ceased. 
Discomfort and pain at the treatment site is a 
frequent complaint for the patients treated with pro- 
longed firm compress ion.  12'1sA6'25'27'29'3° In some 
patients initial compression may be unsuccessful, and 
subsequent compressions may be needed. 12,15,2s,27,28 
Feld et al.24 reported a relatively low success rate of 
46.7% in the initial compression, which could be 
increased to 66.7% after application of additional 
compressions. The presence of sldn ischemia also 
prevents the use of local compression. 12,1s Most of 
the series reported a failure rate of about 10%. The 
patients in whom compression fails must be treated 
with other methods such as surgical re- 
pair 12'24'2s'28-3° or  induction of thrombosis with 
chemical or physical methods. 16-23 Another limita- 
tion is the recurrence of pseudoaneurysm after ini- 
tially successful treatment, with reported recurrence 
rates of 0% to 20%. 12,ls'2s-30 
We performed ultrasound studies in all patients 
to confirm the presence ofpseudoaneurysm, to iden- 
tify the connecting tract between the femoral artery 
and the pseudoaneurysm, and to guide the position- 
ing of an intravenous catheter in the cavity of pseu- 
doaneurysm. The position of the catheter was recon- 
firmed with ultrasonography by injecting normal 
saline solution that contained microbubbles. The di- 
rection of the catheter was adjusted to point away 
from the connecting tract so that an adverse injection 
ofthrombin directly into the femoral rtery could be 
avoided. Immediately after the thrombin injection, 
blood clot formation was evident under ultrasound 
observation. Spontaneous extension of the coagula- 
tion process in the chamber would occlude the con- 
necting tract to prevent overflow of thrombin back 
into the femoral artery. In our experience, the con- 
necting tracts between the pseudoaneurysm and the 
femoral artery were usually quite small and tortuous, 
which was an unfavorable situation f r regurgitation 
of the injected thrombin solution. 
The thrombin we used was obtained from bovine 
blood. As in previous reports, intravascular injections 
of bovine thrombin did not result in significant ad- 
verse reactions, such as disseminated intravascular 
coagulation, distal vascular obstruction, or allergic 
reaction. 16,2°,23,al,32 However, as a foreign protein, it 
is always possible for thrombin to induce some kinds 
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of immunologic reaction. The safety of the intravas- 
cular use of thrombin eeds further evaluation. 
None of our patients' pseudoaneurysms recurred 
after successful coagulation with thrombin injection. 
It is interesting to note that during follow-up the 
initially large coagulated pseudoaneurysm hrank in 
size to became scarcely detectable by palpation. This 
phenomenon is physiologic, analogous to wound 
healing in the human body. a3 
From our l imited experiences, we demonstrated 
that the induct ion of coagulation by thrombin injec- 
tion directly into the cavit T of pseudoaneurysms un- 
der cont inuous ultrasound guidance is simple, much 
less t ime-consuming, devoid of discomfort as a result 
of firm compression and immobil ity, and has a high 
success rate. We therefore recommend thrombin in- 
jection for the treatment of  selected pseudoaneu- 
rysms of peripheral arteries. 
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ERRATUM 
It has been brought o the Editors' attention that in the report entitled "Antisense oligonucleotide to proto-oncogene 
c-myb inhibits the formation of  intimal hyperplasia in experimental vein grafts" by Gregory J. Fulton, Mark G. Davies, 
Walter J. Koch, Helge Dalen, Einar Svendsen, and Per-Otto Hagen J Vase Surg 1997;25:453-63), the foomote symbols 
in Table I were incorrect. The corrected table follows: 
Table I. Dimensional nalysis 
Antisense Nonsense 
Control Pluronic gel c-myb Sense c-myb c-myb p 
Intimal thickness (p~m) 70 -+ 4 72 _+ 4 44 + 61-:~ 65 + 5 68 + 9 0.01 
Medial thickness (btm) 65 ± 5 58 -+ 6 65 _+ 16 76 + 4 64 + 8 0.53 
Luminal area (mm 2) 20.5 ± 1.5 26.9 ± 2.8 21.3 -+ 4.3 24.0 +_ 1.9 31.2 ± 6.9 0.13 
Intimal area (mm 2) 1.14 ± 0.09 1.32 4- 0.12 0.57 + 0.09§11 1.11 + 0.12 0.98 ± 0.30 0.01 
Medial area (ram 2) 1.08 ± 0.11 1.08 + 0.12 1.01 + 0.28 1.36 -- 0.06 1.30 ± 0.25 0.41 
Intimal ratio 0.52 ± 0.02 0.55 + 0.03 0.38 ± 0.04* 0.45 ± 0.02 0.49 ± 0.07 0.03 
Luminal index 39.4 ± 2.6 44.1 + 2.9 44.1 ± 4.4 43.5 ± 3.8 47.0 ± 5.3 0.39 
Intimal and medial dimensions from the mid-section of grafts from the five experimental groups. The data are expressed asthe mean + 
SEM of the thickness (microns) and area (mm 2) for the intima and the media of the vessels from each group. Intimal ratio = intimal 
area/intimal + medial areas. Luminal index = luminal diameter/Cross-sectional wall thickness. 
p < 0.05 considered as significant (Kruskal-Wallis nonparametric test with Dunn's post hoc analysis). 
*p <0.0I antisense versus control/gel alone. 
~p < 0.01 antisense versus control/gel alone. 
~p < 0.0I antisense versus ense/nonsense. 
§p < 0.01 antisense versus control/gel alone. 
liP < 0.05 antisense versus ense/nonsense. 
